SC 13G/A 1 ea154794-13ga6garchik_ipsidy.htm AMENDMENT NO. 6 TO SCHEDULE 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 6)*

IPSIDY INC.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

46264C206

(CUSIP Number)

December 31, 2021

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☒

Rule 13d-1(c)

☐

Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 46264C206

1.		Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only) Stephen J. Garchik
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐
3.		SEC Use Only
4.		Citizenship or Place of Organization USA

Number of Shares Beneficially Owned by Each Reporting Person With:	5.	Sole Voting Power 2,239,349(1)
	6.	Shared Voting Power 0
	7.	Sole Dispositive Power 2,239,349 (1)
	8.	Shared Dispositive Power 0

9.		Aggregate Amount Beneficially Owned by Each Reporting Person 2,239,349 (1)
10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ☐
11.		Percent of Class Represented by Amount in Row (9) 9.6%
12.		Type of Reporting Person (See Instructions) IN

(1)

Includes (i) 1,769,541 shares of common stock held by Mr. Garchik personally, (ii) 78,175 shares of common stock held by Marla Garchik, Mr. Garchik’s wife, (iii) 166,667 shares of common stock held by the Garchik 2019 Irrevocable Trust (“2019 Trust”) of which Mr. Garchik is a trustee and beneficiary, (iv) 11,667 shares of common stock held by Garchik Universal Limited Partnership, which Mr. Garchik jointly controls with his sister, (v) 89,306 shares of common stock held by the Marla Garchik 2020 Irrevocable Trust (the “2020 Trust”) of which Mr. Garchik is a beneficiary, (vi) a common stock purchase warrant to acquire 83,334 shares of common stock at $4.50 per share held by the 2019 Trust and (vii) a common stock purchase warrant to acquire 40,660 shares of common stock at $4.50 per share held by the 2020 Trust. The above percent of common stock is based on 23,206,155 shares of common stock outstanding as of November 9, 2021 as disclosed in the Company’s Schedule 14A Proxy Statement filed with the Securities and Exchange Commission on November 19, 2021.

Page 2 of 5

Item 1.	(a)	Name of Issuer

		Ipsidy Inc. (the “Issuer”)

	(b)	Address of Issuer’s Principal Executive Offices

		670 Long Beach Blvd.
		Long Beach, New York 11561

Item 2.	(a)	Name of Person Filing

		Stephen J. Garchik

	(b)	Address of Principal Business Office or, if none, Residence

		2474 South Ocean Boulevard
		Highland Beach, Florida 33487

	(c)	Citizenship

		USA

	(d)	Title of Class of Securities

		Common stock, $0.0001 par value per share, of the Issuer (the “Common Stock”) and Common Stock Purchase Warrants to acquire Common Stock.

	(e)	CUSIP Number

		46264C206

Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	Not applicable.

Item 4.	Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a)

Amount beneficially owned: 2,239,349 (1)

(b)

Percent of class: 9.6%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: 2,239,349 (1)

(ii)

Shared power to vote or to direct the vote: 0

(iii)

Sole power to dispose or to direct the disposition of: 2,239,349 (1)

(iv)

Shared power to dispose or to direct the disposition of: 0

(1)

Includes (i) 1,769,541 shares of common stock held by Mr. Garchik personally, (ii) 78,175 shares of common stock held by Marla Garchik, Mr. Garchik’s wife, (iii) 166,667 shares of common stock held by the Garchik Irrevocable 2019 Trust (“2019 Trust”) of which Mr. Garchik is a trustee, (iv) 11,667 shares of common stock held by Garchik Universal Limited Partnership, which Mr. Garchik jointly controls with his sister, (v) 89,306 shares of common stock held by Marla Garchik Irrevocable 2020 Trust (the “2020 Trust”) of which Mr. Garchik is a beneficiary, (vi) a common stock purchase warrant to acquire 83,334 shares of common stock at $4.50 per share held by the 2019 Trust and (vii) a common stock purchase warrant to acquire 40,660 shares of common stock at $4.50 per share held by the 2020 Trust. The above percent of common stock is based on 23,206,155 shares of common stock outstanding as of November 9, 2021 as disclosed in the Company’s Schedule 14A Proxy Statement filed with the Securities and Exchange Commission on November 19, 2021.

Page 3 of 5

Item 5.	Ownership of Five Percent or Less of a Class

	Not applicable.

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.

	Not applicable.

Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

	Not applicable.

Item 8.	Identification and Classification of Members of the Group

	Not applicable.

Item 9.	Notice of Dissolution of Group

	Not applicable.

Item 10.	Certification

	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 4 of 5

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 1, 2022	/s/ Stephen J. Garchik
	Stephen J. Garchik

Page 5 of 5

SEC Form SC 13G/A filed by Ipsidy Inc. (Amendment)